[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

NKTR

Nektar Therapeutics is set to release top-line data from its Phase 2b study on June 24, 2025, with investors expressing both optimism and caution.

About NKTR

Nektar Therapeutics ($NKTR) is a biotechnology company focused on developing and commercializing innovative medicines.

Engagements: XXXXXX #

Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXXXXX
Daily Average: XXXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXXXX -XX%
6 Months: XXXXXXXXX +3,114%
1 Year: XXXXXXXXX +495%
1-Year High: XXXXXXXXX on 2025-06-24
1-Year Low: X on 2024-09-29

Social Network	X	Reddit	YouTube
Engagements	XXXXXX	XX	X

Mentions: XXX #

Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: XXX
Daily Average: XXX
1 Week: XX -XX%
1 Month: XXXXX -XX%
6 Months: XXXXXX +4,679%
1 Year: XXXXXX +1,977%
1-Year High: XXXXX on 2025-06-25
1-Year Low: X on 2024-09-29

Social Network	X	Reddit	YouTube
Mentions	XXX	XX	X

Creators: XX #

Creators Line Chart
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning NKTR in the last XX hours which is down XX% from XXX in the previous XX hours Daily Average: XXX
1 Week: XX -XX%
1 Month: XXXXX -XX%
6 Months: XXXXXX +4,120%
1 Year: XXXXXX +3,452%
1-Year High: XXXXX on 2025-06-25
1-Year Low: X on 2024-09-26

Sentiment: XX% #

Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% +4%
1 Month: XX% -XX%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-07-30
1-Year Low: XX% on 2024-08-22

Most Supportive Themes

Buyout/Partnership Potential: (40%) Positive sentiment around the potential for a buyout or partnership, especially given the CEO's history of successful deals and the promising nature of the drug.
Anticipation of Rezolve-AD Data: (35%) Optimism stemming from the upcoming Rezolve-AD Phase 2b data release and the potential for positive results.
Positive Drug Potential: (20%) Positive commentary on the potential of the drug and its mechanism of action, particularly in comparison to other treatments.

Most Critical Themes

Disappointment with past trial results: (5%) Concerns about disappointing data from the XXX trial and the lack of progress in the past years.

Network engagement breakdown:

Network	Positive	%	Neutral	%	Negative	%
X	XXXXX	XX%	XXXXX	XX%	XXX	X%
Reddit	X	X%	X	X%	X	X%
YouTube	X	X%	X	X%	X	X%

Total	XXXXX	XX%	XXXXX	XX%	XXX	X%

Top assets mentioned In the posts about NKTR in the last XX hours

Sarepta Therapeutics, Inc. (SRPT) Regeneron Pharmaceuticals Inc (REGN) Eli Lilly and Company (LLY) Eli Lilly and Company (LLY) Apogee Therapeutics, Inc. Common Stock (APGE) Bitcoin Incognito (XBI) Akropolis (AKRO) Viking Therapeutics, Inc (VKTX) Synthetify (SNY) BridgeBio Pharma, Inc. Common Stock (BBIO)

Top topics mentioned In the posts about NKTR in the last XX hours